Andreas Raabe, Adragos Pharma CEO
Sanofi sells Japanese manufacturing site to CDMO but maintains supply agreement
Sanofi is selling off a piece of its manufacturing operations in Japan to CDMO Adragos Pharma, although will continue to have its products manufactured at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.